Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 7Colorectal Neoplasms 4Breast Neoplasms 4Small Cell Lung Carcinoma 3Neoplasms 3Lung Neoplasms 3Stomatitis 2Male Urogenital Diseases 2Cardiovascular Diseases 2Carcinoma, Non-Small-Cell Lung 2Vascular Diseases 1Ulcer 1Sexual Dysfunction, Physiological 1Rectal Neoplasms 1Radiation-induced Injuries in Patients With Rectal Cancer 1Radiation Injuries 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Non-melanoma Skin Cancer 1Neurotoxicity Syndromes 1Myocardial Ischemia 1Myocardial Infarction 1Lymphoma, Follicular 1Heart Diseases 1Head and Neck Neoplasms 1Fibrosis 1Fatigue 1Eye Diseases 1Erectile Dysfunction 1Dyspareunia 1

Interventions

Radiotherapy 4Paclitaxel 4Carboplatin 4Sodium Chloride 3Oxaliplatin 3Cyclophosphamide 3Vincristine 2Surveys and Questionnaires 2Procarbazine 2Prednisolone 2Methotrexate 2Mental Status and Dementia Tests 2Magnetic Resonance Spectroscopy 2Magnesium Sulfate 2Leucovorin 2Duloxetine Hydrochloride 2Doxorubicin 2Dexamethasone 2Cytarabine 2Calcium Gluconate 2Amifostine 2Acupuncture Therapy 2neurotropin 1motexafin gadolinium 1haloperidol decanoate 1glutamic acid diethyl ester 1glucarpidase 1fludarabine phosphate 1fludarabine 1axicabtagene ciloleucel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neurotoxicity Syndromes × Vitamin E × Clear all
NCT00363129 2016-07-06

Vitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
207 enrolled 13 charts

Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡